Gallacher Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Gallacher Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$407.69 - $446.08 $6,115 - $6,691	-15 Reduced 2.43%	602 $252 Million
Q4 2023 Feb 06, 2024	BUY	$343.0 - $410.68 $2,401 - $2,874	7 Added 1.15%	617 $251 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $8,116 - $8,699	24 Added 4.1%	610 $212 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $184,250 - $206,219	586 New	586 $206 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gallacher Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gallacher Capital Management LLC with notifications on news.